Christopher Davis Davis Selected Advisers
Christopher Davis is chairman of Davis Advisors, a multi-generational investment firm known for research-intensive equity management. The firm’s strategies often emphasize financials and other businesses where long-term ownership and careful accounting analysis matter. Davis is a frequent public commentator on active management and long-horizon investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$410M |
| 2 |
LyondellBasell Industries
LYB
|
+$332M |
| 3 |
JBS
JBS N.V.
JBS
|
+$224M |
| 4 |
Sea Limited
SE
|
+$151M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$138M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$1.01B |
| 2 |
Darling Ingredients
DAR
|
+$131M |
| 3 |
MGM Resorts International
MGM
|
+$89.9M |
| 4 |
Teck Resources
TECK
|
+$76.8M |
| 5 |
Markel Group
MKL
|
+$64.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 29.86% |
| 2 | Healthcare | 16.53% |
| 3 | Communication Services | 11.84% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Energy | 7.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Capital One
COF
$134B
| $1.56B | 7.15% |
8,539,736
-75,030
| -0.9% | -$15.7M |
|
|
CTRA
2
DELISTED
Coterra Energy
CTRA
| $1.3B | 5.99% |
37,119,404
+4,581,896
| +14% | +$138M |
|
3
US Bancorp
USB
$96.7B
| $1.16B | 5.31% |
22,237,960
+196,201
| +0.9% | +$10.8M |
|
4
Viatris
VTRS
$18.7B
| $1.06B | 4.85% |
78,211,191
+33,207
| +0% | +$465K |
|
5
Meta Platforms (Facebook)
META
$1.4T
| $984M | 4.52% |
1,719,156
-33,818
| -2% | -$21.7M |
|
|
6
MGM Resorts International
MGM
$11B
| $899M | 4.13% |
24,295,338
-2,524,864
| -9% | -$89.9M |
|
7
Alphabet (Google) Class A
GOOGL
$4.22T
| $890M | 4.09% |
3,094,659
-24,101
| -0.8% | -$7.57M |
|
8
CVS Health
CVS
$119B
| $879M | 4.04% |
12,239,666
-520,845
| -4% | -$40.1M |
|
9
Tyson Foods
TSN
$20.6B
| $839M | 3.85% |
13,090,689
+263,149
| +2% | +$16.3M |
|
|
10
Markel Group
MKL
$22.2B
| $734M | 3.37% |
383,433
-31,727
| -8% | -$64.4M |
|
11
Amazon
AMZN
$2.79T
| $713M | 3.28% |
3,425,252
-4,010
| -0.1% | -$883K |
|
12
Berkshire Hathaway Class A
BRK.A
$1.06T
| $663M | 3.04% |
923
-20
| -2% | -$14.7M |
|
13
Wells Fargo
WFC
$254B
| $652M | 2.99% |
8,190,871
-67,160
| -0.8% | -$5.77M |
|
|
14
Cigna
CI
$73.3B
| $596M | 2.74% |
2,233,929
+1,481,077
| +197% | +$410M |
|
15
Texas Instruments
TXN
$241B
| $553M | 2.54% |
2,849,671
-3,556
| -0.1% | -$720K |
|
|
16
Teck Resources
TECK
$33.9B
| $548M | 2.51% |
10,584,663
-1,434,946
| -12% | -$76.8M |
|
|
JBS
17
JBS N.V.
JBS
$45.5B
| $471M | 2.16% |
26,244,660
+14,389,919
| +121% | +$224M |
|
|
18
LyondellBasell Industries
LYB
$21.8B
| $451M | 2.07% |
+5,596,588
| New | +$332M |
|
19
Solventum
SOLV
$15.2B
| $413M | 1.9% |
6,330,325
+110,253
| +2% | +$8.19M |
|
|
20
Applied Materials
AMAT
$391B
| $409M | 1.88% |
1,197,102
-3,004,196
| -72% | -$1.01B |
|
21
Chubb
CB
$132B
| $390M | 1.79% |
1,195,391
+8,744
| +0.7% | +$2.81M |
|
|
22
Berkshire Hathaway Class B
BRK.B
$1.06T
| $359M | 1.65% |
749,846
+9,971
| +1% | +$4.89M |
|
23
UnitedHealth
UNH
$350B
| $338M | 1.55% |
1,247,476
-25,924
| -2% | -$7.72M |
|
24
Trip.com Group
TCOM
$29B
| $326M | 1.5% |
6,555,112
+1,501,723
| +30% | +$87.5M |
|
25
Quest Diagnostics
DGX
$27B
| $317M | 1.46% |
1,617,813
+27,930
| +2% | +$5.43M |
|
Similar funds
Christopher Davis's Q1 2026 Portfolio in Review
As of Q1 2026, Christopher Davis held 114 positions worth $21.8B, down 2.1% from $22.2B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Christopher Davis's Q1 2026 filing shows 6 new, 64 increased, 36 reduced and 2 closed positions. Its largest new stake was LyondellBasell Industries: 5,596,588 shares worth $451M. The largest sale was Applied Materials, an estimated $1.01B.
By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Communication Services.
- Christopher Davis's largest Q1 2026 buy was LyondellBasell Industries: 5,596,588 shares worth $451M.
- Christopher Davis added most to Cigna in Q1 2026, an estimated $410M increase.
- Christopher Davis's biggest Q1 2026 reduction was Applied Materials, cutting an estimated $1.01B.
- Christopher Davis fully exited UDR in Q1 2026, selling an estimated $4.16M.
- Christopher Davis's ten largest holdings make up 47% of its $21.8B portfolio in Q1 2026.
- Christopher Davis opened 6 new positions and closed 2 in Q1 2026.
- Christopher Davis's portfolio value fell 2.1% quarter-over-quarter to $21.8B.
Based on Davis Selected Advisers's 13F filing for Q1 2026, filed 7 May 2026.